1.75 semaglutide GLP-1 Drug Fails to Quell Alzheimer's in Novo Nordisk Trials providing better and longer Wegovy® - TMates

The patient required treatment and monitoring in an ICU to make a full recovery, they write

In January, Novo Nordisk started selling a pill form of Wegovy, its previously injection-only weight loss medication

The 42-year-old from Dallas, Texas, took Wegovy and experienced major nausea a side effect that has continued even after she stopped the medication

However, sometimes the hair loss can intensify and become more visible, causing concern and prompting the search for solutions

The question of long-term use To make the matter more complex, initial studies seem to suggest people who lose weight with GLP-1s will need to continue taking the drugs in order to keep the weight off